Study On The Improvement Of State Drug Procurement Pricing Legal System

The core of this paper is to improve the national drug procurement price legal system,so as to achieve the goal of market-oriented government price intervention,and finally achieve the social effect of stabilizing drug prices and promoting healthy and sustainable development in the field of pharmaceuticals.The background of this study in society is the rapid increase of medical expenses,the extremely high price of drugs,the increase of risk level of medical insurance fund,and the threat to the realization of citizens' right to health.The legislative background of this study is the revision of the Drug Administration Law(implemented on December 1,2019),the promulgation and implementation of the Basic Health and Health Promotion Law(implemented on June 1,2020)and the Civil Code(implemented on January 1,2021),which are the main legislative background of this study.The national strategic background of this study is the release of Action Of Healthy China(2019-2030).The national drug procurement price system is the core of the drug procurement management system and one of the important means and ways for the government to intervene in the price in time and appropriately.It has the characteristics of administration and marketization,complexity,multidimensional,crossover and symbiosis.In this paper,with problem-oriented,goal-oriented and result-oriented,the history and present situation of Chinese drug procurement price system is studied through literature research,historical analysis and comparative study.Compared to he relevant drug price management system in major economies abroad,the structural problems and causes of the current national drug procurement price system in China are studied and some suggestions for the further improvement of the system are proposed.This paper includes introduction,three chapters of text and conclusion.In the introduction,the research questions are put forward followed by the research objectives,the relevant literature and describes the research scope and methods.The first chapter analyzes the current situation and problems of the national drug procurement price system.This chapter takes the historical evolution of the national drug procurement price system as the starting point,analyzes the course and characteristics of the development of the national drug procurement management system in China,and summarizes the successful experience of the national drug procurement price system in China.It also puts forward 18 problems in seven aspects: the current Price Law,the legislation of the national drug procurement price rules under the Drug Administration Law,the formation mechanism of the national drug procurement price,the national drug procurement price guarantee mechanism,the legal responsibility of violation of the drug procurement price rules and the improvement of the related rules.The second chapter analyzes the causes of the existing structural problems in China's national drug procurement price system.The internal causes of the problems are pointed out,including the health rights attribute changes,incomplete choice of patients,drugs,duality of people's livelihood,oligopoly of drug market,information asymmetry,demand rigidity,high-tech innovation and macro-strategic status.The four external market causes of the problems are followed,including imbalance between supply and demand in health field,failure of regulation mechanism of drug price market,insufficient investment of local pharmaceutical enterprises in marketing and R & D innovation and monopoly of upstream API price.Chapter ?,with the above research,20 solutions on the improvement of the national drug procurement price system in China are proposed,including the Price Law,the legislation of the national drug procurement price system,the trigger mechanism of the national drug procurement price,the formation mechanism of the national drug procurement price,the national drug procurement price guarantee mechanism,the legal responsibility of the drug procurement price system and the related system.Finally,the conclusion of the study is whether theory or practice,the government's timely and appropriate intervention in drug prices is reasonable and necessary in the world;government price intervention can't be a crude and simple administrative order,the government should partake more in the market and adjust the market imbalance and failure by market-oriented means;the construction and design of the system should focus on the market,focus on details,adopt fine legislative technology,so that it can balance the legal relationship and interest relationship between the main bodies of the market,facilitate thedrug prices fluctuate around their intrinsic value,and make the market return to its original order.